{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:38:44Z","timestamp":1790624324116,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["TL1TR001428"],"award-info":[{"award-number":["TL1TR001428"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["R01 CA169300"],"award-info":[{"award-number":["R01 CA169300"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["R01 CA197477"],"award-info":[{"award-number":["R01 CA197477"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jbo.2021.100357","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T03:05:37Z","timestamp":1616555137000},"page":"100357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Using a combination of gangliosides and cell surface vimentin as surface biomarkers for isolating osteosarcoma cells in microfluidic devices"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0151-2249","authenticated-orcid":false,"given":"Henrietta O.","family":"Fasanya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo J.","family":"Dopico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Yeager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z. Hugh","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar W.","family":"Siemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2021.100357_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4419-0284-9_1","article-title":"The epidemiology of osteosarcoma","volume":"152","author":"Ottaviani","year":"2009","journal-title":"Cancer Treat Res."},{"issue":"1","key":"10.1016\/j.jbo.2021.100357_b0010","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12032-014-0430-9","article-title":"Circulating tumor cells in sarcomas: a brief review","volume":"32","author":"Chang","year":"2015","journal-title":"Med Oncol."},{"issue":"6","key":"10.1016\/j.jbo.2021.100357_b0015","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00132-017-3429-z","article-title":"Benign tumours and tumour-like lesions of the bone : General treatment principles","volume":"46","author":"Fritzsche","year":"2017","journal-title":"Orthopade."},{"issue":"2","key":"10.1016\/j.jbo.2021.100357_b0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4274\/Mirt.138","article-title":"Limits of Tumor Detectability in Nuclear Medicine and PET","volume":"21","author":"...","year":"2012","journal-title":"Mol Imaging Radionucl Ther."},{"issue":"1","key":"10.1016\/j.jbo.2021.100357_b0025","first-page":"33","article-title":"Pediatric Osteosarcoma: An Updated Review. Indian J Med Paediatr","volume":"38","author":"Taran","year":"2017","journal-title":"Oncol."},{"issue":"19","key":"10.1016\/j.jbo.2021.100357_b0030","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1200\/JCO.2007.15.8923","article-title":"Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer","volume":"26","author":"Cohen","year":"2008","journal-title":"J Clin Oncol."},{"issue":"8","key":"10.1016\/j.jbo.2021.100357_b0035","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","article-title":"Circulating tumor cells, disease progression, and survival in metastatic breast cancer","volume":"351","author":"Cristofanilli","year":"2004","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1016\/j.jbo.2021.100357_b0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1039\/C3LC51017D","article-title":"Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip","volume":"14","author":"Sheng","year":"2014","journal-title":"Lab Chip."},{"key":"10.1016\/j.jbo.2021.100357_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/617421","article-title":"Significance of Circulating Tumor Cells Detected by the Cell Search System in Patients with Metastatic Breast Colorectal and Prostate Cancer","volume":"2010","author":"Miller","year":"2010","journal-title":"J Oncol."},{"issue":"2","key":"10.1016\/j.jbo.2021.100357_b0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/cyto.a.22613","article-title":"Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the Cell Search(\u00ae) CTC test","volume":"87","author":"Adams","year":"2015","journal-title":"Cytometry A."},{"issue":"1","key":"10.1016\/j.jbo.2021.100357_b0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3892\/mco.2014.428","article-title":"Epithelial cell adhesion molecule is expressed in a subset of sarcomas and correlates to the degree of cytological atypia in leiomyosarcomas","volume":"3","author":"Ward","year":"2015","journal-title":"Mol Clin Oncol."},{"issue":"1","key":"10.1016\/j.jbo.2021.100357_b0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF02259905","article-title":"Gangliosides","volume":"57","author":"Wiegandt","year":"1966","journal-title":"Ergeb Physiol."},{"issue":"3","key":"10.1016\/j.jbo.2021.100357_b0065","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ijc.2910410303","article-title":"Expression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, naevi, primary and metastatic melanoma","volume":"41","author":"Hersey","year":"1988","journal-title":"Int J Cancer."},{"issue":"10","key":"10.1016\/j.jbo.2021.100357_b0070","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1182\/blood-2006-08-039347","article-title":"Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs","volume":"109","author":"Martinez","year":"2007","journal-title":"Blood."},{"issue":"2","key":"10.1016\/j.jbo.2021.100357_b0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0005-2760(94)90034-5","article-title":"Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord","volume":"1214","author":"Svennerholm","year":"1994","journal-title":"Biochim Biophys Acta."},{"issue":"26","key":"10.1016\/j.jbo.2021.100357_b0080","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1200\/JCO.2011.41.3807","article-title":"Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission","volume":"30","author":"Cheung","year":"2012","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.jbo.2021.100357_b0085","first-page":"319","article-title":"3F8 monoclonal antibody treatment of patients with stage IV neuroblastoma: a phase II study","volume":"385","author":"Cheung","year":"1994","journal-title":"Prog Clin Biol Res."},{"issue":"14","key":"10.1016\/j.jbo.2021.100357_b0090","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa0911123","article-title":"Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma","volume":"363","author":"Yu","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jbo.2021.100357_b0095","doi-asserted-by":"crossref","unstructured":"Albertini MR, Hank JA, Gadbaw B, et al. Phase II trial of hu14.18-IL2 for patients with metastatic melanoma. Cancer Immunol Immunother. Dec 2012;61(12):2261-2271.","DOI":"10.1007\/s00262-012-1286-5"},{"issue":"22","key":"10.1016\/j.jbo.2021.100357_b0100","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1200\/JCO.2004.11.035","article-title":"Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients","volume":"22","author":"King","year":"2004","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.jbo.2021.100357_b0105","doi-asserted-by":"crossref","unstructured":"Saleh MN, Khazaeli MB, Wheeler RH, et al. Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma. Hum Antibodies Hybridomas. Jan 1992;3(1):19-24.","DOI":"10.3233\/HAB-1992-3104"},{"issue":"16","key":"10.1016\/j.jbo.2021.100357_b0110","first-page":"4342","article-title":"Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma","volume":"52","author":"Saleh","year":"1992","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.jbo.2021.100357_b0115","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1073\/pnas.90.5.1972","article-title":"GD2 ganglioside on human T-lymphotropic virus type I-infected T cells: possible activation of beta-1,4-N-acetylgalactosaminyltransferase gene by p40tax","volume":"90","author":"Furukawa","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"10.1016\/j.jbo.2021.100357_b0120","first-page":"2844","article-title":"High expression of ganglioside alpha-2,8-sialyltransferase (GD3 synthase) gene in adult T-cell leukemia cells unrelated to the gene expression of human T-lymphotropic virus type I","volume":"56","author":"Okada","year":"1996","journal-title":"Cancer Res."},{"issue":"33","key":"10.1016\/j.jbo.2021.100357_b0125","doi-asserted-by":"crossref","first-page":"29828","DOI":"10.1074\/jbc.M414041200","article-title":"Mechanisms for the apoptosis of small cell lung cancer cells induced by anti-GD2 monoclonal antibodies: roles of anoikis","volume":"280","author":"Aixinjueluo","year":"2005","journal-title":"J Biol Chem."},{"issue":"7","key":"10.1016\/j.jbo.2021.100357_b0130","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1349-7006.2002.tb01324.x","article-title":"An anti-GD2 monoclonal antibody enhances apoptotic effects of anti-cancer drugs against small cell lung cancer cells via JNK (c-Jun terminal kinase) activation","volume":"93","author":"Yoshida","year":"2002","journal-title":"Jpn J Cancer Res."},{"issue":"10","key":"10.1016\/j.jbo.2021.100357_b0135","first-page":"4244","article-title":"Ganglioside G(D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis","volume":"61","author":"Yoshida","year":"2001","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.jbo.2021.100357_b0140","doi-asserted-by":"crossref","first-page":"36936","DOI":"10.18632\/oncotarget.16294","article-title":"IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells","volume":"8","author":"Battula","year":"2017","journal-title":"Oncotarget."},{"issue":"9","key":"10.1016\/j.jbo.2021.100357_b0145","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4161\/cbt.11.9.15178","article-title":"Mesenchymal stem cells expressing GD2 and CD271 correlate with breast cancer-initiating cells in bone marrow","volume":"11","author":"De Giorgi","year":"2011","journal-title":"Cancer Biol Ther."},{"issue":"29","key":"10.1016\/j.jbo.2021.100357_b0150","doi-asserted-by":"crossref","first-page":"47454","DOI":"10.18632\/oncotarget.17665","article-title":"Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype","volume":"8","author":"Liang","year":"2017","journal-title":"Oncotarget."},{"issue":"19","key":"10.1016\/j.jbo.2021.100357_b0155","doi-asserted-by":"crossref","first-page":"31592","DOI":"10.18632\/oncotarget.16363","article-title":"GD2 expression in breast cancer","volume":"8","author":"Orsi","year":"2017","journal-title":"Oncotarget."},{"issue":"5","key":"10.1016\/j.jbo.2021.100357_b0160","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00008390-199212000-00009","article-title":"Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanoma","volume":"2","author":"Bajorin","year":"1992","journal-title":"Melanoma Res."},{"issue":"3","key":"10.1016\/j.jbo.2021.100357_b0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00063030-200317030-00002","article-title":"Gangliosides as therapeutic targets for cancer","volume":"17","author":"Fredman","year":"2003","journal-title":"BioDrugs."},{"issue":"10","key":"10.1016\/j.jbo.2021.100357_b0170","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1158\/1078-0432.CCR-10-0043","article-title":"Anti-GD3 chimeric sFv-CD28\/T-cell receptor zeta designer T cells for treatment of metastatic melanoma and other neuroectodermal tumors","volume":"16","author":"Lo","year":"2010","journal-title":"Clin Cancer Res."},{"issue":"2","key":"10.1016\/j.jbo.2021.100357_b0175","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/156800910791054167","article-title":"Anti-GD2 antibody therapy for GD2-expressing tumors","volume":"10","author":"Navid","year":"2010","journal-title":"Curr Cancer Drug Targets."},{"issue":"3","key":"10.1016\/j.jbo.2021.100357_b0180","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1517\/14728222.2014.986459","article-title":"Disialoganglioside GD2 as a therapeutic target for human diseases","volume":"19","author":"Suzuki","year":"2015","journal-title":"Expert Opin Ther Targets."},{"issue":"1-3","key":"10.1016\/j.jbo.2021.100357_b0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0009-3084(86)90054-X","article-title":"Tumor-associated glycolipid antigens, their metabolism and organization","volume":"42","author":"Hakomori","year":"1986","journal-title":"Chem Phys Lipids."},{"issue":"17","key":"10.1016\/j.jbo.2021.100357_b0190","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1158\/1078-0432.CCR-09-0737","article-title":"The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research","volume":"15","author":"Cheever","year":"2009","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.jbo.2021.100357_b0195","doi-asserted-by":"crossref","unstructured":"Dobrenkov K, Ostrovnaya I, Gu J, Cheung IY, Cheung NK. Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults. Pediatr Blood Cancer. 10 2016;63(10):1780-1785.","DOI":"10.1002\/pbc.26097"},{"issue":"4","key":"10.1016\/j.jbo.2021.100357_b0200","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/cncr.28461","article-title":"Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma","volume":"120","author":"Roth","year":"2014","journal-title":"Cancer."},{"issue":"9","key":"10.1016\/j.jbo.2021.100357_b0205","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.1349-7006.2012.02344.x","article-title":"Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2\/GD3","volume":"103","author":"Shibuya","year":"2012","journal-title":"Cancer Sci."},{"issue":"20","key":"10.1016\/j.jbo.2021.100357_b0210","first-page":"5377","article-title":"Localization of GD2-specific monoclonal antibody 3F8 in human osteosarcoma","volume":"47","author":"Heiner","year":"1987","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.jbo.2021.100357_b0215","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1172\/JCI38339","article-title":"Introducing intermediate filaments: from discovery to disease","volume":"119","author":"Eriksson","year":"2009","journal-title":"J Clin Invest."},{"issue":"18","key":"10.1016\/j.jbo.2021.100357_b0220","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","article-title":"Vimentin in cancer and its potential as a molecular target for cancer therapy","volume":"68","author":"Satelli","year":"2011","journal-title":"Cell Mol Life Sci."},{"issue":"6","key":"10.1016\/j.jbo.2021.100357_b0225","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1158\/0008-5472.CAN-13-1739","article-title":"Universal marker and detection tool for human sarcoma circulating tumor cells","volume":"74","author":"Satelli","year":"2014","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.jbo.2021.100357_b0230","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF00391353","article-title":"Two distinct cell lines derived from a human osteosarcoma","volume":"115","author":"Kawai","year":"1989","journal-title":"J Cancer Res Clin Oncol."},{"issue":"1","key":"10.1016\/j.jbo.2021.100357_b0235","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1034\/j.1600-0609.2003.02766.x","article-title":"CAL72: a human osteosarcoma cell line with unique effects on hematopoietic cells","volume":"70","author":"Rochet","year":"2003","journal-title":"Eur J Haematol."},{"key":"10.1016\/j.jbo.2021.100357_b0240","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-4939-7144-2_3","article-title":"A Novel Microfluidic Device for Isolation of Circulating Tumor Cells from Pancreatic Cancer Blood Samples","volume":"1634","author":"Varillas","year":"2017","journal-title":"Methods Mol Biol."},{"issue":"23","key":"10.1016\/j.jbo.2021.100357_b0245","doi-asserted-by":"crossref","first-page":"7688","DOI":"10.1002\/ange.201901412","article-title":"Integration of Lateral Filter Arrays with Immunoaffinity for Circulating-Tumor-Cell Isolation","volume":"131","author":"Chen","year":"2019","journal-title":"Angew Chem Int Ed Engl."},{"issue":"11","key":"10.1016\/j.jbo.2021.100357_b0250","first-page":"5262","article-title":"Differential expression of ganglioside GD3 by human leukocytes and leukemia cells","volume":"44","author":"Siddiqui","year":"1984","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.jbo.2021.100357_b0255","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1158\/1078-0432.CCR-04-0378","article-title":"Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases","volume":"10","author":"Allard","year":"2004","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.jbo.2021.100357_b0260","doi-asserted-by":"crossref","unstructured":"Okubo K, Uenosono Y, Arigami T, et al. Clinical impact of circulating tumor cells and therapy response in pancreatic cancer. Eur J Surg Oncol. 06 2017;43(6):1050-1055.","DOI":"10.1016\/j.ejso.2017.01.241"},{"issue":"45","key":"10.1016\/j.jbo.2021.100357_b0265","doi-asserted-by":"crossref","first-page":"78965","DOI":"10.18632\/oncotarget.20697","article-title":"Size-based detection of sarcoma circulating tumor cells and cell clusters","volume":"8","author":"Hayashi","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.jbo.2021.100357_b0270","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2147\/CMAR.S176515","article-title":"Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery","volume":"10","author":"Wu","year":"2018","journal-title":"Cancer Manag Res."},{"issue":"3","key":"10.1016\/j.jbo.2021.100357_b0275","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/cncr.26339","article-title":"Cell surface receptor expression patterns in osteosarcoma","volume":"118","author":"Hassan","year":"2012","journal-title":"Cancer."},{"key":"10.1016\/j.jbo.2021.100357_b0280","doi-asserted-by":"crossref","unstructured":"Park JA, Cheung NV. GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma. J Hematol Oncol. 12 2020;13(1):172.","DOI":"10.1186\/s13045-020-01012-y"},{"key":"10.1016\/j.jbo.2021.100357_b0285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-030-43032-0_5","article-title":"HER2-Targeted Therapy in Osteosarcoma","volume":"1257","author":"Gill","year":"2020","journal-title":"Adv Exp Med Biol."},{"issue":"10","key":"10.1016\/j.jbo.2021.100357_b0290","doi-asserted-by":"crossref","first-page":"e111597","DOI":"10.1371\/journal.pone.0111597","article-title":"\u201cSentinel\u201d circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease","volume":"9","author":"Ilie","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.jbo.2021.100357_b0295","doi-asserted-by":"crossref","unstructured":"Alix-Panabi\u00e8res C, Pantel K. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy. Cancer Discov. 05 2016;6(5):479-491.","DOI":"10.1158\/2159-8290.CD-15-1483"},{"issue":"1","key":"10.1016\/j.jbo.2021.100357_b0300","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13569-014-0020-9","article-title":"Ganglioside GD2 expression is maintained upon recurrence in patients with osteosarcoma","volume":"5","author":"Poon","year":"2015","journal-title":"Clin Sarcoma Res."},{"issue":"1","key":"10.1016\/j.jbo.2021.100357_b0305","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/vsu.12579","article-title":"Retrospective Evaluation of Whole Body Computed Tomography for Tumor Staging in Dogs with Primary Appendicular Osteosarcoma","volume":"46","author":"Talbott","year":"2017","journal-title":"Vet Surg."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137421000117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137421000117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:19:00Z","timestamp":1761941940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137421000117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":61,"alternative-id":["S2212137421000117"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2021.100357","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using a combination of gangliosides and cell surface vimentin as surface biomarkers for isolating osteosarcoma cells in microfluidic devices","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2021.100357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100357"}}